Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 5 filers reported holding Santen Pharmaceutical Co Ltd in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -50.0% | 199 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 199 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 199 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 199 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 199 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 199 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 1,577,090 | $25,659,000 | 0.02% |
| MEEDER ASSET MANAGEMENT INC | 199 | $3,000 | 0.00% |
| Private Capital Group, LLC | 159 | $3,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 625 | $10,000 | 0.00% |